Michael Myers, Chief Executive Officer at Quoin Pharmaceuticals, Ltd. (QNRX), bought 20,490 shares at $4.88 ($100K) on 2026-08-31, disclosed to the SEC on 2026-09-01.
CEO Michael Myers purchased $99,991.20 worth of shares at $4.88, signaling confidence in the stock's recent surge. This executive buying comes as the stock has rallied nearly 50% over the last 30 days.
QNRX has surged 49.66% over the past 30 days, currently trading at $6.54, which is 88.74% above its 52-week low of $3.465.
Insider Ups Holding By 1,515,200% During Year: Simply Wall St. reported on 2026-01-23 that insiders have significantly increased their holdings over the last year. Sector Update: Healthcare Stocks Decline Friday Afternoon: MT Newswires reported on 2026-08-28 that the broader healthcare sector was under pressure.
The stock is down 11.33% over the past year despite recent gains, and the sector experienced declines on 2026-08-28 according to MT Newswires.
Something here stands out, but not much.
| Filing → |
| INPH | BUY | 2012-05-23 | $29K | — | Filing → |
| INPH | SELL | 2012-04-20 | $62K | — | Filing → |
| INPH | SELL | 2012-04-17 | $52K | — | Filing → |